Stelazine® brand of trifluoperazine
should be tried in chronic schizophrenics
Clinical evidence shows that 'Stelazine' can produce significant improvement in at least 30%-40% of a given group of chronic schizophrenics. Because of this demonstrated effectiveness, 'Stelazine should be tried in chronic schizophrenics, no matter how discouraging the results of previous therapies may have been -- no matter whether the patient is hyperactive, withdrawn, or has delusions or hallucinations.
And it should be given at high enough dosages for long enough periods of time.
Smith, Kline & French Laboratories
leaders in psychopharmaceutical research